Free Download - Contraception For Adolescent And Young Adult Women: A Clinician`S Handbook9/16/2017 ![]() Tailoring Clinical Services to Address the Unique Needs of Adolescents from the Pregnancy Test to Parenthood. Blue Sale Price EMEA isbn authoreditor1_lastname originators title subtitle series_title volume_number edition_number copyright_year number_of_arabic_pages. Most women are candidates for implantable contraception; there are few medical disorders where the risk of the method exceeds the benefit (e.g., current breast cancer). Lesbian, gay, bisexual, and transgender (LGBT) youth face multiple challenges during their adolescence. This chapter addresses the developmental, psychosocial. More than 4,500 ebooks and many book collections, including archive collections of critical historical material, as well as publisher and topical collections. 9780786289332 0786289333 Sonando Con el Jefe, Lilian Darcy 9788872880760 8872880769 The Ten Books on the Way of Life and Great Deed of the Carmelites (including the. · Parental acceptability for HPV vaccination. Because the HPV vaccine is recommended for young adolescent girls, parents will have authority for making most. The material in this report originated in the National Center for HIV, STD and TB Prevention, Harold W. Jaffe, M.D., Director; Division of HIV/AIDS Prevention. Incorporating HIV Prevention into the Medical Care of Persons Living with HIV | News. Date: July 1. 8, 2. Source: Centers for Disease Control and Prevention (CDC). URL: http: //www. The material in this report originated in the National Center for HIV, STD and TB Prevention, Harold W. Jaffe, M. D., Director; Division of HIV/AIDS Prevention ¿ Surveillance and Epidemiology, Robert S. Janssen, Director; Division of HIV/AIDS Prevention ¿ Intervention, Research, and Support, Robert S. Janssen, M. D., Acting Director. Reducing transmission of human immunodeficiency virus (HIV) in the United States requires new strategies, including emphasis on prevention of transmission by HIV- infected persons. Through ongoing attention to prevention, risky sexual and needle- sharing behaviors among persons with HIV infection can be reduced and transmission of HIV infection prevented. Medical care providers can substantially affect HIV transmission by screening their HIV- infected patients for risk behaviors; communicating prevention messages; discussing sexual and drug- use behavior; positively reinforcing changes to safer behavior; referring patients for services such as substance abuse treatment; facilitating partner notification, counseling, and testing; and identifying and treating other sexually transmitted diseases (STDs). To help incorporate HIV prevention into the medical care of HIV- infected persons, CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America developed these recommendations. The recommendations are general and apply to incorporating HIV prevention into the medical care of all HIV- infected adolescents and adults, regardless of age, sex, or race/ethnicity. They are intended for all persons who provide medical care to HIV- infected persons (e. The recommendations were developed by using an evidence- based approach. For each recommendation, the strength of the recommendation, the quality of available evidence supporting the recommendation, and the outcome for which the recommendation is rated are provided. The recommendations are categorized into three major components: screening for HIV transmission risk behaviors and STDs, providing brief behavioral risk- reduction interventions in the office setting and referring selected patients for additional prevention interventions and other related services, and facilitating notification and counseling of sex and needle- sharing partners of infected persons. Despite substantial advances in the treatment of human immunodeficiency virus (HIV) infection, the estimated number of annual new HIV infections in the United States has remained at 4. HIV prevention in this country has largely focused on persons who are not HIV infected, to help them avoid becoming infected. However, further reduction of HIV transmission will require new strategies, including increased emphasis on preventing transmission by HIV- infected persons (2,3). HIV- infected persons who are aware of their HIV infection tend to reduce behaviors that might transmit HIV to others (4- -7). Nonetheless, recent reports suggest that such behavioral changes often are not maintained and that a substantial number of HIV- infected persons continue to engage in behaviors that place others at risk for HIV infection (8- -1. Reversion to risky sexual behavior might be as important in HIV transmission as failure to adopt safer sexual behavior immediately after receiving a diagnosis of HIV (1. Unprotected anal sex appears to be occurring more frequently in some urban centers, particularly among young men who have sex with men (MSM) (1. Bacterial and viral sexually transmitted diseases (STDs) in HIV- infected men and women receiving outpatient care have been increasingly noted (1. HIV transmission. Further, despite declining syphilis prevalence in the general U. S. population, sustained outbreaks of syphilis among MSM, many of whom are HIV infected, continue to occur in some areas; rates of gonorrhea and chlamydial infection have also risen for this population (1. Rising STD rates among MSM indicate increased potential for HIV transmission, both because these rates suggest ongoing risky behavior and because STDs have a synergistic effect on HIV infectivity and susceptibility (2. Studies suggest that optimism about the effectiveness of highly active antiretroviral therapy (HAART) for HIV may be contributing to relaxed attitudes toward safer sex practices and increased sexual risk- taking by some HIV- infected persons (1. Injection drug use also continues to play a key role in the HIV epidemic; at least 2. AIDS cases among adults and adolescents with known HIV risk category reported to CDC in 2. In some large drug- using communities, HIV seroincidence and seroprevalence among injection drug users (IDUs) have declined in recent years (2. This decline has been attributed to several factors, including increased use of sterile injection equipment, declines in needle- sharing, shifts from injection to noninjection methods of using drugs, and cessation of drug use (3. However, injection- drug use among young adult heroin users has increased substantially in some areas (3. Clinicians providing medical care to HIV- infected persons can play a key role in helping their patients reduce risk behaviors and maintain safer practices and can do so with a feasible level of effort, even in constrained practice settings. Clinicians can greatly affect patients' risks for transmission of HIV to others by performing a brief screening for HIV transmission risk behaviors; communicating prevention messages; discussing sexual and drug- use behavior; positively reinforcing changes to safer behavior; referring patients for such services as substance abuse treatment; facilitating partner notification, counseling, and testing; and identifying and treating other STDs (3. These measures may also decrease patients' risks of acquiring other STDs and bloodborne infections (e. Managed care plans can play an important role in HIV prevention by incorporating these recommendations into their practice guidelines, educating their providers and enrollees, and providing condoms and educational materials. In the context of care, prevention services might be delivered in clinic or office environments or through referral to community- based programs. Some clinicians have expressed concern that reimbursement is often not provided for prevention services and note that improving reimbursement for such services might enhance the adoption and implementation of these guidelines. This report provides general recommendations for incorporating HIV prevention into the medical care of all HIV- infected adolescents and adults, regardless of age, sex, or race/ethnicity. The recommendations are intended for all persons who provide medical care to HIV- infected persons (e. They may also be useful to those who deliver prevention messages (e. Special considerations may be needed for some subgroups (e. However, it is beyond the scope of this report to address special considerations of subgroups. Furthermore, the recommendations focus on sexual and drug- injection behaviors, since these behaviors are responsible for nearly all HIV transmission in the United States. Separate guidelines have been published for preventing perinatal transmission (3. These recommendations were developed by using an evidence- based approach (Table 1). The strength of each recommendation is indicated on a scale of A (strongest recommendation for) to E (recommendation against); the quality of available evidence supporting the recommendation is indicated on a scale of I (strongest evidence for) to III (weakest evidence for), and the outcome for which the recommendation is rated is provided.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |